Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,7167,760,79
Msft0,29
Nokia3,3043,49050,51
IBM0,90
Mercedes-Benz Group AG72,372,32-1,00
PFE1,80
09.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 08.05.2024
Curaleaf Hldg Rg (US Other OTC (Pink Sheets))
Závěr k 8.5.2024 Změna (%) Změna (USD) Objem obchodů (ks)
5,30 -0,75 -0,04 292 530
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.05.2024
Popis společnosti
Obecné informace
Název společnostiCuraleaf Holdings Inc
TickerCURA
Kmenové akcie:Ordinary Shares Subordinate Voting
Kmenové akcie:Ordinary Shares Multiple Voting
RICCURA.TO
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 5 650
Akcie v oběhu k 29.04.2024 741 612 756
MěnaUSD
Kontaktní informace
Ulice420 Lexington Avenue
MěstoNEW YORK
PSČ10170
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 814 510 117

Business Summary: Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Curaleaf Holdings Inc revenues increased 6% to $1.35B. Net loss before extraordinary items decreased 11% to $229.8M. Revenues reflect Management fee income increase of 21% to $5.9M. Lower net loss reflects Loss on impairment decrease of 19% to $67.1M (expense), Share-based compensation decrease of 29% to $20M (expense), Other income - Balancing value increase from $1.8M (expense) to $4.6M (income).
Odvětvová klasifikace
TRBC2012Recreational Pharmaceuticals
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations



  • Poslední aktualizace: 09.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardBoris Jordan56
President, Chief Executive OfficerMatt Darin4309.05.202204.01.2022
Executive Vice Chairman of the BoardJoseph Lusardi4901.01.2021
Chief Financial OfficerEdward Kremer5008.08.202208.08.2022
Chief People OfficerTyneeha Rivers4524.05.202224.05.2022
Chief Investment OfficerCamilo Lyon4708.08.202208.08.2022
Chief Compliance OfficerJames Shorris62
Chief Legal OfficerPeter Clateman55
Chief Strategy OfficerMitch Hara5803.08.202203.08.2022